...
首页> 外文期刊>International immunology. >Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses.
【24h】

Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses.

机译:通过谱系树和突变分析揭示了卵泡性淋巴瘤,弥漫性大B细胞淋巴瘤和原发中枢神经系统淋巴瘤中Ig基因的多样化和选择。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL) and primary central nervous system lymphoma are B cell malignancies. FL and DLBCL have a germinal center origin. We have applied mutational analyses and a novel algorithm for quantifying shape properties of mutational lineage trees to investigate the nature of the diversification, somatic hypermutation and selection processes that affect B cell clones in these malignancies and reveal whether they differ from normal responses. Lineage tree analysis demonstrated higher diversification and mutations per cell in the lymphoma clones. This was caused solely by the longer diversification times of the malignant clones, as their recent diversification processes were similar to those of normal responses, implying similar mutation frequencies. Since previous analyses of antigen-driven selection were shown to yield false positives, we performed a corrected analysis of replacement and silent mutation patterns, which revealed selection against replacement mutations in the framework regions, responsible for the structural integrity of the B cell receptor, but not for positive selection for replacements in the complementary determining regions. Most replacements, however, were neutral or conservative, suggesting that if at all selection operates in these malignancies it is for structural B cell receptor integrity but not for antigen binding.
机译:滤泡性淋巴瘤(FL),弥漫性大B细胞淋巴瘤(DLBCL)和原发性中枢神经系统淋巴瘤是B细胞恶性肿瘤。 FL和DLBCL有生发中心起源。我们已经应用了突变分析和一种新颖的算法来量化突变谱系树的形状特性,以研究影响这些恶性肿瘤中B细胞克隆的多样性,体细胞超突变和选择过程的性质,并揭示它们是否与正常反应不同。谱系树分析显示淋巴瘤克隆中每个细胞具有更高的多样性和突变。这仅是由于恶性克隆较长的多样化时间所致,因为它们最近的多样化过程与正常反应相似,这意味着相似的突变频率。由于先前对抗原驱动选择的分析显示会产生假阳性,因此我们对置换和沉默突变模式进行了校正分析,这揭示了针对构架区中负责B细胞受体结构完整性的置换突变的选择,但是而不是在互补决定区域中积极选择替代品。然而,大多数替代是中性或保守的,表明如果选择完全在这些恶性肿瘤中进行,那是为了结构B细胞受体的完整性,而不是抗原的结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号